Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Deselsulfavirine - Viriom

Next Previous
Search
Drug Profile

Deselsulfavirine - Viriom

Alternative Names: Depulfavirine; VM 1500A; VM 1500A LAI

Latest Information Update: 28 Mar 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Roche
  • Developer Viriom
  • Class Antiretrovirals; Antivirals; Small molecules
  • Mechanism of Action Non-nucleoside reverse transcriptase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Phase II HIV infections

Most Recent Events

  • 28 Mar 2024 No recent reports of development identified for clinical-Phase-Unknown development in HIV-infections(Combination therapy) in Unknown (Parenteral)
  • 28 May 2022 No recent reports of development identified for phase-I development in HIV-infections(Prevention) in Russia (IM, Injection)
  • 24 Jan 2022 Viriom plans a phase II/III trial for HIV infections (Treatment-experienced, Combination therapy) in Russia (IM, Injection), in April 2022 (NCT05204394)

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top